A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity

Area of Science:

• Cellular signaling pathways
• Molecular biology
• Oncogene research

Background:

• The proto-oncogene Raf regulates cell growth and differentiation.
• A Raf-activated signaling pathway independent of MEK1,2-ERK1,2 exists, but its components were unknown.

Purpose of the Study:

• To identify novel signaling cascades downstream of Raf.
• To characterize a new kinase activated by Raf and its role in cellular specificity.

Main Methods:

• Identification and characterization of a novel mitogen-activated protein kinase, p97.
• Assessing p97 activation and association with Raf upon cellular stimulation.
• Investigating p97's selective responsiveness to fibroblast growth factor (FGF) versus epidermal growth factor (EGF) in neuronal cells.
• Analyzing p97's substrate specificity, including phosphorylation of transcription factors Elk-1, Ets-2, and MEF2C.
• Determining p97 expression patterns in different cell types.

Main Results:

• A new ERK5-related kinase, p97, was identified and found to be activated and associated with Raf.
• p97 exhibits selective activation by FGF but not EGF in neuronal cells, contrasting with ERK5's response to EGF.
• p97 phosphorylates Elk-1 and Ets-2, but not MEF2C, at transactivating sites.
• ERK5 phosphorylates MEF2C but not Elk-1 or Ets-2.
• p97 is expressed in primary neural and NIH 3T3 cells.

Conclusions:

• A novel Raf-activated signaling pathway distinct from the canonical Raf-MEK1,2-ERK1,2 cascade has been identified.
• The p97 pathway provides a mechanism for selective cellular responses to different growth factors, leading to discrete biological outcomes.
• This discovery expands our understanding of Raf-mediated signaling and its role in cellular specificity.